Lentivector targeting to dendritic cells.

6. McKee, TD, Grandi, P, Mok, W, Alexandrakis, G, Insin, N, Zimmer, JP et al. (2006). Degradation of fi brillar collagen in a human melanoma xenograft improves the effi cacy of an oncolytic herpes simplex virus vector. Cancer Res 66: 2509–2513. 7. Wang, Y, Hallden, G, Hill, R, Anand, A, Liu, TC, Francis, J et al. (2003). E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models. Nat Biotechnol 21: 1328–1335. 8. Gaggar, A, Shayakhmetov, DM and Lieber, A (2003). CD46 is a cellular receptor for group B adenoviruses. Nat Med 9: 1408–1412. 9. Kambara, H, Saeki, Y and Chiocca, EA (2005). Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus. Cancer Res 65: 11255–11258. 10. Power, AT and Bell, JC (2007). Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer. Mol Ther 15: 660–665. 11. Laurie, SA, Bell, JC, Atkins, HL, Roach, J, Bamat, MK, O’Neil, JD et al. (2006). A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization. Clin Cancer Res 12: 2555–2562. 12. Thorne, SH, Hwang, TH, O’Gorman, WE, Bartlett, DL, Sei, S, Kanji, F et al. (2007). Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963. J Clin Invest 117: 3350–3358. 13. Wang, Y, Thorne, S, Hannock, J, Francis, J, Au, T, Reid, T et al. (2005). A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenoviruses. Clin Cancer Res 11: 351–360. 14. Rots, MG, Elferink, MG, Gommans, WM, Oosterhuis, D, Schalk, JA, Curiel, DT et al. (2006). An ex vivo human model system to evaluate specifi city of replicating and non-replicating gene therapy agents. J Gene Med 8: 35–41. 15. Wein, LM, Wu, JT and Kirn, DH (2003). Validation and analysis of a mathematical model of a replicationcompetent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res 63: 1317–1324.